Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis
A Randomized, Double-blind, Placebo-controlled Multi-center Study of GB-0998 for Treatment of Systemic Sclerosis A Randomized, Double-blind, Placebo-controlled Multi-center Study of GB-0998 for Treatment of System ...